Acetylcysteine lysinate

N/A

Report date: 2022/12/31 17:22:15
NME

Base Information

Drug NameAcetylcysteine lysinate
Drug Alias NameL-Lysine-N-acetyl-L-cysteinateN-acetylcysteine lysinateNacystelyn
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUndefined mechanism
TargetsNot applicable
Therapy Area/IndicationsAutism Spectrum DisorderCystic Fibrosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
Originator CompaniesGalephar PharmaceuticalsLaboratoires Smb Sa
China Registration ClassN/A

Develop Information

Active CompaniesStanford University
Inactive CompaniesGalephar PharmaceuticalsLaboratoires Smb Sa
Active IndicationsAutism Spectrum Disorder
Inactive IndicationsCystic Fibrosis

Other Information

ATC CodeN/A
Related LinksN/A